Emergence of the G118R Pan-Integrase Resistance Mutation as a Result of Low Compliance to a Dolutegravir-Based cART
Research output: Contribution to journal › Journal article › Research › peer-review
Documents
- Fulltext
Final published version, 705 KB, PDF document
HIV-1 resistance towards integrase inhibitors is a potential threat of the success of HIV-1 combination treatment. G118R is a rare drug resistance mutation conferring pan-integrase resistance. Here, we describe the occurrence of G118R in a HIV-1 subtype-B-positive individual with major compliance problems, detected while the patient was on dolutegravir-based cART. We speculate the pre-selection of M184I/V aided the occurrence of G118R in this case, and discuss the robustness of dolutegravir-based therapies.
Original language | English |
---|---|
Journal | Infectious Disease Reports |
Volume | 14 |
Issue number | 4 |
Pages (from-to) | 501-504 |
ISSN | 2036-7430 |
DOIs | |
Publication status | Published - 2022 |
- drug resistance, HIV-1, integrase inhibitors
Research areas
ID: 324815316